Advanced Biomed Growth Metrics (2024-2025) | ADVB

Growth Metrics Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
Assets Growth (1y) (Quarter) 207.56%140.90%
Assets (QoQ) (Quarter) 84.00%65.52%-54.49%73.81%
Capital Expenditures Growth (1y) (Quarter) 108.30%-62.17%-91.14%220.71%
Capital Expenditures (QoQ) (Quarter) 299.47%-62.49%-153.52%120.72%809.66%-91.21%628.74%
Cash & Equivalents Growth (1y) (Quarter) -4.64%94.62%11.35%0.36%-1.40%
Cash & Equivalents (QoQ) (Quarter) -4.07%-2.09%1.50%0.03%95.80%-43.98%-8.52%-1.73%
Cash from Investing Activities Growth (1y) (Quarter) -108.30%62.17%91.14%-220.71%
Cash from Investing Activities (QoQ) (Quarter) -299.47%62.49%153.52%-120.72%-809.66%91.21%-628.74%
Cash from Operations Growth (1y) (Quarter) -257.24%-224.48%-1,956.41%181.88%
Cash from Operations (QoQ) (Quarter) 55.35%93.76%-1,397.63%-756.46%59.44%60.47%159.63%
EBIT Growth (1y) (Quarter) -298.70%-31.02%13.32%-45.68%1,308.33%
EBIT (QoQ) (Quarter) -626.71%23.37%67.19%-118.20%-138.81%49.30%44.86%1,909.81%
EBT Growth (1y) (Quarter) -298.70%-31.02%13.32%-45.68%1,308.33%
EBT (QoQ) (Quarter) -626.71%23.37%67.19%-118.20%-138.81%49.30%44.86%1,909.81%
Enterprise Value Growth (1y) (Quarter) 4.64%-94.62%-11.42%-1.45%0.91%
Enterprise Value (QoQ) (Quarter) 4.07%2.09%-1.50%-0.03%-95.80%43.95%7.59%2.29%
EPS (Basic) Growth (1y) (Quarter) -200.00%-40.00%25.00%-100.00%1,166.67%
EPS (Basic) (QoQ) (Quarter) -400.00%20.00%75.00%-200.00%-133.33%57.14%33.33%1,700.00%
EPS (Weighted Average and Diluted) Growth (1y) (Quarter) -200.00%-40.00%25.00%-100.00%1,133.33%
EPS (Weighted Average and Diluted) (QoQ) (Quarter) -400.00%20.00%75.00%-200.00%-133.33%57.14%33.33%1,650.00%
Free Cash Flow Growth (1y) (Quarter) -266.63%-195.63%-1,132.66%180.92%
Free Cash Flow (QoQ) (Quarter) 49.08%90.61%-773.58%-778.08%58.94%60.87%157.35%
Net Cash Flow Growth (1y) (Quarter) 538.34%-1,033.35%-148.02%197.01%
Net Cash Flow (QoQ) (Quarter) 56.89%266.81%-107.44%8,289.61%-211.47%92.93%115.04%
Net Income Growth (1y) (Quarter) -125.95%-31.02%13.32%-45.68%56.07%
Net Income (QoQ) (Quarter) -626.71%23.37%67.19%-23.66%-321.39%49.30%44.86%62.71%
Net Income towards Common Stockholders Growth (1y) (Quarter) -125.95%-31.02%13.32%-45.68%56.07%
Net Income towards Common Stockholders (QoQ) (Quarter) -626.71%23.37%67.19%-23.66%-321.39%49.30%44.86%62.71%
Profit After Tax Growth (1y) (Quarter) -524.65%-31.02%13.32%-45.68%855.36%
Profit After Tax (QoQ) (Quarter) -626.71%23.37%67.19%-241.86%-52.43%49.30%44.86%1,872.53%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) -76.13%-75.79%
Property, Plant & Equipment (Net) (QoQ) (Quarter) -11.40%-64.76%124.69%-65.48%
Return on Assets (QoQ) (Quarter) 0.000.000.00
Return on Capital Employed (QoQ) (Quarter) -18958.0027,869.0010,611.00
Return on Equity Growth (1y) (Quarter) 1.002.00
Return on Equity (QoQ) (Quarter) -1.002.000.000.000.00
Shareholder's Equity Growth (1y) (Quarter) 214.48%929.61%109.08%174.64%1,431.69%
Shareholder's Equity (QoQ) (Quarter) -352.89%434.12%-34.24%-43.41%567.14%-15.79%-13.61%215.62%